Business Insider

Biotheranostics presents new studies of the Breast Cancer Index® at the 2020 ASCO conference, expanding its clinical utility as a predictive tool for hormone receptor positive ...

San Diego, CA, May 29, 2020 (GLOBE NEWSWIRE) -- Biotheranostics announces several new studies demonstrating comprehensive validation and clinical utility of its Breast Cancer Index genomic assay for ...

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), announced ...
Business Wire

Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures ...

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that the prospective, real-world ORACLE ...